Stephen Campbell

Almac Group Ltd. manufactures and distributes pharmaceutical products. The firm’s services include diagnostics, API services and chemical development, pharmaceutical development, analytical and solid state services, clinical services, clinical technologies and commercial services. The company was founded by Allen McClay in 2002 and is headquartered in Craigavon, the United Kingdom.

Part of The McClay Foundation, Almac Discovery Ltd. is a British company that engages in the discovery and development of novel drugs. The company is based in Belfast, UK and was founded in 2003.

Part of The McClay Foundation, Almac Sciences Ltd. is a company based in Craigavon, UK that was founded in 2001. The British company provides custom chemical synthesis, technical testing, and analysis services.

Part of The McClay Foundation, Almac Clinical Technologies Ltd. is a British company that supplies pharmaceutical products. The company is based in Craigavon, UK and was founded in 2006.

Part of Chemical Synthesis Services Business, Almac Sciences (Scotland) Ltd. is a British company that produces custom peptides and proteins. The company is based in Penicuik, UK.

Part of The McClay Foundation, Almac Diagnostic Services Ltd. offers a complete range of peptide and protein services, from catalogue products to GMP manufacture, for early phase to commercial launch. The company is based in Craigavon, UK. Almac Group provides a range of contract pharmaceutical development and manufacturing services. Almac Interactive Response Technology (IRT) technologies suite offers 3 modes to configure your IXRS platform varying in levels of customizations, speed to go live, and costs for your clinical supply chain study. The British company is one of the leading, multi-faceted, solution providers within the niche and complex market of clinical trial supply. Almac Diagnostic Services was initially founded as a spin-out company from Queen's University in 2002 called Arradx, which was incorporated into the Almac Group in 2004.

Part of The McClay Foundation, Almac Pharma Services Ltd. is a British company that provides a range of contract pharmaceutical development and manufacturing services. The company is based in Craigavon, UK. The company's services include adjudication of in-transit and clinical site excursions, compliance management of shipments & sites, and comprehensive GDP monitoring. The company also offers customised CDX solutions that are unique to companies worldwide. Almac Clinical Services has not experienced any significant operational impact due to the coronavirus outbreak and their service levels remain unchanged. John McQuaid has been the CEO of the company since 1994.

Almac Group (UK) Ltd. offers contract development and manufacturing services. Its services encompass research and development, biomarker discovery and development, formulation development, clinical trial supply, IXRS technology, commercial-scale manufacture, and companion diagnostic development. The firm serves the pharmaceutical and biotechnology sectors. The company is headquartered in Craigavon, the United Kingdom.

Part of The McClay Foundation, Almac Diagnostics 2004 Ltd. is a British dormant company. The company is based in Craigavon, UK. Almac Diagnostics 2004 was founded in 2004.

Part of Almac Sciences Group Ltd., 2007 Gal Ltd. is a British non-trading company. The company is based in Craigavon, UK. Founded in 2004.